Jeil Pharm has ranked among the top searched stocks on 6 days within the past month.

As of 9:30 AM on the 11th, Jeil Pharm is trading at 53,200 KRW, down 1.12% from the previous day. This represents a 49.65% increase compared to May 14. Jeil Pharm is known as a company spun off from Jeil Pharma Holdings.

Over the past 5 days, individual investors have net sold 34,271 shares, while foreigners and institutions have net bought 22,713 shares and 13,533 shares, respectively.

On June 10, Jeil Pharm was a market topic due to a rise following news of the Nafamostat clinical trial.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing